FDA.reportPublic FDA data

← NDC directory

FDA compounder NDC directory

Browse every current FDA compounder source row, including records that do not contain a usable NDC.

Compounder NDC directory#

Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.

Compounder directory page 1 of 1 · 8 matching rows.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCBrandNonproprietary nameActive ingredientsPeriodNormalizationSource date
OurPharma LLC04142263773013-105573013-1055-1Fentanyl Citrate; Ropivacaine Hydrochloride2 ug/1 mL; 2 mg/1 mL2026-1valid2026-10-06
OurPharma LLC73013-105573013-1055-1Fentanyl Citrate- Ropivacaine HClfentanyl citrate, ropivacaine hydrochloride2 ug/1 mL; 2 mg/1 mL2026-1valid2026-09-18
OurPharma LLC04142263773013-105573013-1055-1Fentanyl Citrate; Ropivacaine Hydrochloride2 ug/1 mL; 2 mg/1 mL2025-2valid2026-10-06
OurPharma LLC73013-105573013-1055-1Fentanyl Citrate- Ropivacaine HClfentanyl citrate, ropivacaine hydrochloride2 ug/1 mL; 2 mg/1 mL2025-2valid2026-09-18
OurPharma LLC04142263773013-105573013-1055-1Fentanyl Citrate; Ropivacaine Hydrochloride2 ug/1 mL; 2 mg/1 mL2025-1valid2026-10-06
OurPharma LLC73013-105573013-1055-1Fentanyl Citrate- Ropivacaine HClfentanyl citrate, ropivacaine hydrochloride2 ug/1 mL; 2 mg/1 mL2025-1valid2026-09-18
OurPharma LLC04142263773013-105573013-1055-1Fentanyl Citrate; Ropivacaine Hydrochloride2 ug/1 mL; 2 mg/1 mL2024-2valid2026-10-06
OurPharma LLC73013-105573013-1055-1Fentanyl Citrate- Ropivacaine HClfentanyl citrate, ropivacaine hydrochloride2 ug/1 mL; 2 mg/1 mL2024-2valid2026-09-18